Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00628238. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00003764. IPD Sharing: Not stated. Countries: 4. Publications: 4.
Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00103558. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04754035. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00274989. IPD Sharing: NO. Countries: 1. Publications: 4.
Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
ClinicalTrials.gov study NCT00278213. IPD Sharing: NO. Countries: 2. Publications: 1.
Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00021749. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00049075. IPD Sharing: NO. Countries: 2. Publications: 1.
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
ClinicalTrials.gov study NCT01118234. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT05254743. IPD Sharing: YES. Countries: 23. Publications: 0.
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
ClinicalTrials.gov study NCT01351935. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT03986034. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab
ClinicalTrials.gov study NCT00349349. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
ClinicalTrials.gov study NCT00881920. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01558167. IPD Sharing: NO. Countries: 1. Publications: 1.
Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00201721. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00046488. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02500407. IPD Sharing: YES. Countries: 7. Publications: 15.
A Safety Study in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00283101. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00281892. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.